PROMACTA 12.5 mg/1

PROMACTA 12.5 mg film-coated tablets contain eltrombopag olamine, a medication used to support platelet production. This oral treatment is commonly prescribed for conditions affecting blood cell counts, offering a convenient once-daily option.

PROMACTA is primarily used to increase platelet counts in individuals with certain blood disorders. It works by stimulating the production of platelets in the bone marrow, which can be beneficial for those experiencing low platelet levels. This medication is often considered when other treatments have not been effective or are not suitable.

Common effects of PROMACTA may include nausea, dizziness, and fatigue. Some users also report changes in vision or taste. These effects can vary widely among individuals and are not experienced by everyone taking the medication.

PROMACTA should be handled with care, especially for those with liver issues or a history of blood clots. Regular monitoring of liver function and platelet levels is recommended. Always follow the advice of a healthcare provider regarding the use of this medication.

PROMACTA may interact with certain medications, including antacids and some antibiotics. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, grapefruit products should be avoided as they can affect how the body processes PROMACTA.